drugset
drugset / Trial / NCT01140867

Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy

NCT01140867 ↗

Phase 4 Completed 121 enrolled Eisai Co., Ltd.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The object of this study is to assess the efficacy and safety of zonisamide as adjunctive therapy in patients with uncontrolled partial epilepsy.

Timeline

Start
2008-02-29
Primary completion
2010-08-31
Completion
2011-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Zonisamide Other / unclassified 300 mg —

Indications

epilepsy